Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Short-term Investments (2022 - 2025)

Treace Medical Concepts' Short-term Investments history spans 4 years, with the latest figure at $37.7 million for Q4 2025.

  • For Q4 2025, Short-term Investments fell 41.46% year-over-year to $37.7 million; the TTM value through Dec 2025 reached $37.7 million, down 41.46%, while the annual FY2025 figure was $37.7 million, 41.46% down from the prior year.
  • Short-term Investments reached $37.7 million in Q4 2025 per TMCI's latest filing, down from $49.7 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $141.0 million in Q1 2023 to a low of $37.7 million in Q4 2025.
  • Average Short-term Investments over 4 years is $83.0 million, with a median of $70.7 million recorded in 2024.
  • Peak YoY movement for Short-term Investments: surged 78.4% in 2023, then plummeted 41.64% in 2024.
  • A 4-year view of Short-term Investments shows it stood at $61.8 million in 2022, then soared by 78.4% to $110.2 million in 2023, then tumbled by 41.64% to $64.3 million in 2024, then plummeted by 41.46% to $37.7 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Short-term Investments are $37.7 million (Q4 2025), $49.7 million (Q3 2025), and $61.2 million (Q2 2025).